Patents by Inventor Dafang Wan

Dafang Wan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7205109
    Abstract: The invention provides a method for diagnosing susceptibility of individual cancer (e.g. liver cancer), comprising the steps of detecting individual HC56 gene, transcript and/or protein, and comparing it with normal HC56 gene, transcript and/or protein. The difference show the possibility of individual cancer is higher than that in the normal population. The invention also provides the corresponding detection kit.
    Type: Grant
    Filed: March 21, 2002
    Date of Patent: April 17, 2007
    Assignee: Shanghai Cancer Institute
    Inventors: Dafang Wan, Jianren Gu
  • Patent number: 7112419
    Abstract: The invention relates to a new kind of human protein associated with hepatoma and the polynucleotide encoding the polypeptide and a process for producing the polypeptide by recombinant methods. The present invention also relates to a method of applying the polypeptide for the diagnosis and treatment of various kinds of disease, such as cancer. Further, present invention relates to the antagonist of the polypeptide and therapeutic use of the same. In addition, the invention relates to the use of the same. In addition, the invention relates to the use of polynucleotide encoding the hepatoma associated human protein.
    Type: Grant
    Filed: April 17, 2001
    Date of Patent: September 26, 2006
    Assignee: Shanghai Cancer Institute
    Inventors: Xintai Zhao, Dafang Wan, Jianren Gu
  • Publication number: 20060110737
    Abstract: The invention related to a novel human tumor associated polypeptide CT120, and the encoding polynucleotide, and to the method for producing the polypeptide by recombinant technology, also to the method for diagnosing and treating diseases such as carcinoma using the polypeptide. The invention also related to antagonists against the polypeptide and its uses for treatment, aslo to the uses of the polynucleotide coding for the human tumor-associated protein.
    Type: Application
    Filed: October 8, 2003
    Publication date: May 25, 2006
    Inventors: Jianren Gu, Dafang Wan, Xianghue He
  • Publication number: 20050042616
    Abstract: The invention provides a method for diagnosing susceptibility of individual cancer (e.g. liver cancer), comprising the steps of detecting individual HC56 gene, transcript and/or protein, and comparing it with normal HC56 gene, transcript and/or protein. The difference show the possibility of individual cancer is higher than that in the normal population. The invention also provides the corresponding detection kit.
    Type: Application
    Filed: March 21, 2002
    Publication date: February 24, 2005
    Inventors: Dafang Wan, Jianren Gu
  • Publication number: 20030148331
    Abstract: The invention disclosed a new kind of human protein that associated with hepatoma and the polynucleotide encoding said polypeptide and a process for producing the polypeptide by recombinant methods. It also disclosed the method of applying the polypeptide for the diagnosis and treatment of various kinds of disease, such as cancer. The antagonist of the polypeptide and therapeutic use of the same is also disclosed. In addition, the invention disclosed the use of the same. In addition, the invention refers to the use of polynucleotide encoding said hepatoma associated human protein.
    Type: Application
    Filed: October 8, 2002
    Publication date: August 7, 2003
    Inventors: Xintai Zhao, Dafang Wan, Jianren Gu